Callan Family Office’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Sell
13,553
-421
-3% -$93.5K 0.08% 251
2025
Q4
$2.26M Buy
13,974
+1,730
+14% +$300K 0.05% 329
2025
Q3
$1.85M Sell
12,244
-11,485
-48% -$1.53M 0.06% 275
2025
Q2
$3.05M Buy
23,729
+11,199
+89% +$1.09M 0.1% 219
2025
Q1
$905K Buy
12,530
+303
+2% +$32.3K 0.07% 232
2024
Q4
$1.39M Sell
12,227
-2,762
-18% -$328K 0.09% 193
2024
Q3
$1.49M Buy
14,989
+137
+0.9% +$11.4K 0.25% 47
2024
Q2
$1.29M Buy
+14,852
New +$1.35M 0.25% 47

Other funds holding VRT

Callan Family Office's VRT Position: Q1 2026 in Review

Callan Family Office reduced its Vertiv (VRT) stake by 3% in Q1 2026, selling an estimated $93.5K and leaving 13,553 shares worth $3.4M. The position accounts for 0.08% of the portfolio, ranked #251.

Callan Family Office first reported a position in VRT in Q2 2024 and has held it in 8 quarters since. 1,824 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • Callan Family Office held 13,553 shares of Vertiv worth $3.4M as of Q1 2026.
  • Callan Family Office sold 421 Vertiv shares in Q1 2026, an estimated $93.5K.
  • Vertiv made up 0.08% of Callan Family Office's portfolio in Q1 2026, its #251 holding.
  • Callan Family Office first reported a position in Vertiv in Q2 2024 and has held it in 8 quarters since.
  • 1,824 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.